Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices – US 2019

January 24, 2020 at 7:27 am

MMWR January 24, 2020 V.69 N.3 P.77–83

Summary

What is already known about this topic?

Repeat doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine at 5- and 10-year intervals are safe and immunogenic.

What is added by this report?

ACIP recommendations have been updated to allow either tetanus and diphtheria toxoids (Td) vaccine or Tdap to be used for the decennial Td booster, tetanus prophylaxis for wound management, and for additional required doses in the catch-up immunization schedule if a person has received at least 1 Tdap dose.

What are the implications for public health practice?

Allowing either Tdap or Td to be used in situations where Td only was previously recommended increases provider point-of-care flexibility.

FULL TEXT

https://www.cdc.gov/mmwr/volumes/69/wr/mm6903a5.htm

PDF

https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6903a5-H.pdf

Entry filed under: Infecciones en embarzadas, Inmunizaciones, Medicina del viajero, Prevencion y Control de Infecciones, Profilaxis Antibiótica en Cirugía - PAC, REPORTS, Update.

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America Alerta por el novel coronavirus (nCoV) 2019


Calendar

January 2020
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Most Recent Posts


%d bloggers like this: